|
Hopper, Rachel K; Abman, Steven H; Ivy, D Dunbar (2016) Persistent Challenges in Pediatric Pulmonary Hypertension. Chest 150:226-36
|
|
Laguna, Theresa A; Reilly, Cavan S; Williams, Cynthia B et al. (2015) Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation. Pediatr Pulmonol 50:869-77
|
|
Accurso, Frank J; Van Goor, Fredrick; Zha, Jiuhong et al. (2014) Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data. J Cyst Fibros 13:139-47
|
|
Wagner, Brandie D; Takatsuki, Shinichi; Accurso, Frank J et al. (2013) Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension. PLoS One 8:e80235
|
|
Duncan, Mark; Wagner, Brandie D; Murray, Keri et al. (2012) Circulating cytokines and growth factors in pediatric pulmonary hypertension. Mediators Inflamm 2012:143428
|
|
Ratjen, Felix; Saiman, Lisa; Mayer-Hamblett, Nicole et al. (2012) Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. Chest 142:1259-1266
|
|
Laguna, Theresa A; Wagner, Brandie D; Starcher, Barry et al. (2012) Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation. Pediatr Pulmonol 47:856-63
|
|
Szefler, Stanley J (2011) Advancing asthma care: the glass is only half full! J Allergy Clin Immunol 128:485-94
|
|
Szefler, Stanley J; Dakhama, Azzeddine (2011) New insights into asthma pathogenesis and treatment. Curr Opin Immunol 23:801-7
|
|
Cooley, J; Sontag, M K; Accurso, F J et al. (2011) SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition. Eur Respir J 37:1083-90
|
Showing the most recent 10 out of 45 publications
